From: Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review
Regulators | Keap1/Nrf2 | Biological consequences | Refs |
---|---|---|---|
Cullin3 | Keap1 | Forms the Keap1-Cul3-RBX1 E3 ligase complex and induces Nrf2 polyubiquitination and proteasomal degradation | [36] |
UHRF1 | Keap1 | Down-regulates Keap1 expression by enhancing KEAP1 promoter methylation | [39] |
MBD1 | Keap1 | Down-regulates Keap1 expression by enhancing KEAP1 promoter methylation | [40] |
p62 | Keap1 | Directly binds to Keap1, competitively inhibits the binding of Nrf2 to Keap1, and protects Nrf2 from protein degradation | [30] |
aPKCι | Keap1 | Directly binds to Keap1, competitively inhibits the binding of Nrf2 to Keap1, and protects Nrf2 from protein degradation | [41] |
PALB2 | Keap1 | Directly binds to Keap1, competitively inhibits the binding of Nrf2 to Keap1, and protects Nrf2 from protein degradation | [42] |
KRAL | Keap1 | Directly interacts with miR-141 and increases the expression of Keap1 | [43] |
β-TrCP | Nrf2 | Directly binds to Nrf2 and promotes its ubiquitination and proteasomal degradation | [23] |
HRD1 | Nrf2 | Directly interacts with Nrf2 and promotes its ubiquitination and proteasomal degradation | [38] |
GSK-3β | Nrf2 | Phosphorylates Nrf2 at Ser342 and Ser347 in Neh6 domain | [23] |
ALDOA | Nrf2 | Increases the expression of Nrf2 | [44] |
Kras/ERKaxis | Nrf2 | Increases the expression of Nrf2 | |
GRP78/UPR | Nrf2 | Increases the activity of Nrf2 | [48] |
STAT3 | Nrf2 | Increases the expression of Nrf2 | [14] |
APE1/Ref-1 | Nrf2 | Directly interacts with Nrf2 and inhibits its activity | [49] |
dCK | Nrf2 | Negatively regulates the NRF2 transcriptional activity | [50] |
NRAL | Nrf2 | Directly binds to miR-340-5p, inhibits miR-340-5p-mediated repressing activity of the Nrf2–3’UTR, and increases Nrf2 expression | [51] |